GTCM
WST icon

Gyon Technologies Capital Management’s West Pharmaceutical WST Stock Holding History

Gyon Technologies Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,008
Closed -$284K – 507
2021
Q1 		$284K Buy
+1,008
New +$288K 0.12% 292

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gyon Technologies Capital Management's WST Position: Q2 2021 in Review

Gyon Technologies Capital Management sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 1,008 shares — an estimated $284K sold.

Gyon Technologies Capital Management first reported a position in WST in Q1 2021 and held it in 1 quarter. The position peaked at $284K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Gyon Technologies Capital Management reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 1,008 West Pharmaceutical shares in Q2 2021, an estimated $284K.
  • Gyon Technologies Capital Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 1 quarter.
  • Gyon Technologies Capital Management's West Pharmaceutical position peaked at $284K in Q1 2021.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.